Suppr超能文献

弥漫性毒性甲状腺肿经碘化钾治疗后的甲状腺功能减退

Thyroid failure after potassium iodide treatment of diffuse toxic goiter.

作者信息

Wood L C, Maloof F

出版信息

Trans Assoc Am Physicians. 1975;88:235-47.

PMID:1243786
Abstract
  1. The treatment of Graves' Disease by Potassium Iodide (like thyroidectomy, radioiodine, and antithyroid drugs) is followed by rate failure of thyroid function. 2. These findings suggest that the natural history of Graves' Disease may be one of progression from hyperthyroidism towards a decreased thyroid functional state. This progression may be accelerated by ablative methods of treatment. 3. Certainly, all patients with Graves' Disease, no matter what the treatment may be, should be followed carefully for the rest of their lives. 4. In certain patients, Potassium Iodide appears to be an effective means of controlling the hyperthyroidism of Graves' Disease.
摘要
  1. 碘化钾治疗格雷夫斯病(如同甲状腺切除术、放射性碘和抗甲状腺药物治疗一样)之后会出现甲状腺功能减退。2. 这些发现表明,格雷夫斯病的自然病程可能是从甲状腺功能亢进逐渐发展为甲状腺功能减退状态。这种进展可能会因消融性治疗方法而加速。3. 当然,所有格雷夫斯病患者,无论接受何种治疗,都应在其余生中接受密切随访。4. 对于某些患者,碘化钾似乎是控制格雷夫斯病甲状腺功能亢进的有效手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验